Medicine and Dentistry
Breast Cancer
100%
Neoplasm
59%
Next Generation Sequencing
44%
Patient
33%
Triple Negative Breast Cancer
28%
Hormone Receptor
28%
Overall Survival
27%
Recurrent Disease
26%
Malignant Neoplasm
24%
Tumor Infiltrating Lymphocyte
23%
Epidermal Growth Factor Receptor 2
23%
Receptor Expression
22%
Histopathology
22%
Gamma Urogastrone
21%
Gene Expression
21%
Needle Biopsy
20%
Tumor Gene
20%
Logistic Regression Analysis
20%
Immunohistochemistry
19%
Cancer Types
19%
Tissues
19%
Non Small Cell Lung Cancer
18%
Somatic Mutation
18%
Tissue Microarray
17%
Lung
17%
Adenocarcinoma
17%
Biological Marker
16%
Disease Free Survival
16%
In Situ Hybridization
16%
Colorectal Cancer
15%
Retrospective Study
14%
Ovarian Cancer
14%
Lung Adenocarcinoma
14%
Hazard Ratio
13%
Uterine Cancer
13%
Antiestrogen
13%
Receptor Antibody
13%
Radiomics
13%
Androgen Receptor
13%
Carcinoid Tumor of Lung
13%
Mucosal Melanoma
13%
Breast Tumor
13%
Eczema
13%
Mucinous Carcinoma
13%
Risk Stratification
13%
Sentinel Lymph Node
13%
Learning
13%
Metastatic Breast Cancer
13%
Gastrointestinal Stromal Tumor
13%
Intraductal Carcinoma
13%
Biochemistry, Genetics and Molecular Biology
Mutation
30%
Epidermal Growth Factor Receptor
22%
Next Generation Sequencing
20%
Tumor Gene
20%
Overall Survival
18%
Gene Expression Data
16%
Homologous Recombination
16%
KRAS
15%
In Situ Hybridization
15%
Gene Mutation
13%
Colon
13%
Gene Mutation
13%
Tumor Gene
13%
Eosin
13%
X-Inactivation
13%
Learning
13%
Liquid
13%
Androgen Receptor
13%
Circulating Tumor DNA
13%
P53
12%
Gene Amplification
11%
Fluorescence in Situ Hybridization
11%
Insulin-Like Growth Factor 1 Receptor
10%
Hormone Receptor
10%
BRCA1
9%
Wild Type
9%
Somatic Mutation
9%
Tumor-Infiltrating Lymphocytes
9%
Eosin
8%
Somatic Mutation
8%
Training
8%
X Chromosome
7%
Disease Free Survival
7%
Accuracy
7%
Overall Survival
7%
Case Report
6%
Deep Sequencing
6%
Exome Sequencing
6%
Homologous Recombination
6%
Exome Sequencing
6%
Deep Sequencing
6%
Droplet Digital Polymerase Chain Reaction
6%
B Cell
6%
Antigen Expression
6%
Radiomics
6%
Blood Plasma
6%
Solution and Solubility
6%
BRCA1
6%
Angiogenesis
6%
Angiogenesis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
31%
Breast Cancer
30%
Epidermal Growth Factor Receptor 2
24%
Gamma Urogastrone
21%
Lung Adenocarcinoma
13%
Triple Negative Breast Cancer
13%
Recurrent Disease
13%
Breast Carcinoma
8%
Prognosis
8%
Survival
8%
Gamma Urogastrone
8%
Epidermal Growth Factor Receptor 2
8%
Malignant Neoplasm
8%
Messenger RNA
7%
Biological Marker
7%
Polyethylene Terephthalate
7%
Neoplasm
7%
Somatomedin C Receptor
6%
Triple Negative Breast Cancer
6%
microRNA 34a
6%
Transcription Factor Nrf2
6%
Retina Neovascularization
6%
Diffuse Large B Cell Lymphoma
6%
Adenocarcinoma
6%
Breast Cancer
6%
Pleomorphic Adenoma
6%
Brain Metastasis
6%
DNA
6%
microRNA 34a
6%
Protein Tyrosine Kinase
6%
Human Papillomavirus
6%
Hormone Receptor
6%
Helicobacter Pylori
6%
Thymidylate Synthase
6%
Kelch Like ECH Associated Protein 1
6%
Mouse Model
6%
Cross-Validation
6%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
6%
Tensin
6%
Hormone Receptor
6%
Phosphatase
6%
Somatomedin C Receptor
6%
Lung Cancer
6%
Visceral Metastasis
6%
Progesterone Receptor
5%
Estrogen Receptor
5%
Overall Survival
5%